Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M90,052Revenue $M25,711Net Margin (%)3.8Z-Score2.5
Enterprise Value $M94,049EPS $2.0Operating Margin %7.1F-Score4
P/E(ttm))98.4Cash Flow Per Share $0Pre-tax Margin (%)4.1Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %10.1Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %-9.5Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-29.4ROA % (ttm)1.8Higher Current Ratio y-yN
Dividend Yield %3.9Insider Buy (3m)0ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %343Shares Outstanding M1,263ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$68.49 - $76.31
($73.2)
$ 71.89-2%Sold Out0
AZNJohn Hussman 2014-09-30 Reduce-0.29%$68.49 - $76.31
($73.2)
$ 71.89-2%Reduce -22.37%173,500
AZNGeorge Soros 2014-06-30 Buy 0.08%$62.45 - $81.09
($72.26)
$ 71.890%New holding, 150000 sh.150,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$62.45 - $81.09
($72.26)
$ 71.890%New holding, 40400 sh.40,400
AZNCharles Brandes 2014-06-30 Reduce-0.78%$62.45 - $81.09
($72.26)
$ 71.890%Reduce -71.06%386,058
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$62.45 - $81.09
($72.26)
$ 71.890%Sold Out0
AZNNWQ Managers 2014-06-30 Reduce-0.01%$62.45 - $81.09
($72.26)
$ 71.890%Reduce -24.55%64,475
AZNJohn Hussman 2014-03-31 Add0.96%$58.51 - $68.15
($64.29)
$ 71.8912%Add 714.29%228,000
AZNDavid Dreman 2014-03-31 Add0.14%$58.51 - $68.38
($64.41)
$ 71.8912%Add 26.61%135,439
AZNJoel Greenblatt 2014-03-31 Buy 0.09%$58.51 - $68.38
($64.41)
$ 71.8912%New holding, 95518 sh.95,518
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$58.51 - $68.38
($64.41)
$ 71.8912%Sold Out0
AZNCharles Brandes 2014-03-31 Reduce-0.84%$58.51 - $68.15
($64.29)
$ 71.8912%Reduce -46.73%1,333,894
AZNDavid Dreman 2013-12-31 Reduce-0.34%$49.72 - $59.5
($54.28)
$ 71.8932%Reduce -40.32%106,975
AZNHOTCHKIS & WILEY 2013-12-31 Reduce-0.3%$49.72 - $59.5
($54.28)
$ 71.8932%Reduce -24.9%3,689,214
AZNJohn Hussman 2013-12-31 Reduce-0.11%$49.72 - $59.5
($54.28)
$ 71.8932%Reduce -58.82%28,000
AZNCharles Brandes 2013-09-30 Add0.12%$47.88 - $52.08
($50.24)
$ 71.8943%Add 7.92%2,381,040
AZNJohn Hussman 2013-09-30 Reduce-0.66%$47.88 - $52.08
($50.24)
$ 71.8943%Reduce -81.87%68,000
AZNHOTCHKIS & WILEY 2013-06-30 Add0.68%$47.22 - $53.01
($50.92)
$ 71.8941%Add 131.18%4,944,742
AZNJohn Hussman 2013-06-30 Reduce-1.02%$47.22 - $53.01
($50.92)
$ 71.8941%Reduce -59.76%375,000
AZNJoel Greenblatt 2013-06-30 Sold Out -0.24%$47.22 - $53.01
($50.92)
$ 71.8941%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AZN Mario Gabelli 2014-09-3041,90000.02+3.71%
AZN George Soros 2014-09-30150,0000.010.08
AZN NWQ Managers 2014-09-3064,4750.010.05
AZN David Dreman 2014-09-30117,0030.010.68-0.7%
AZN John Hussman 2014-09-30173,5000.011.1-22.37%
AZN Charles Brandes 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$17319.41view

Press Releases about AZN :

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
    Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 
    Brandes International Equity Fund Q3 Commentary Dec 23 2014 
    Blackhill Bets Almost Half of Portfolio on Williams-Sonoma Nov 10 2014 
    A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio Nov 09 2014 
    Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 
    I Believe AstraZeneca Is Fairly Valued Jul 16 2014 
    A Look at AstraZeneca’s New Drug on Diabetes May 22 2014 
    Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca (AZN) Positive Data From May 11 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 


    More From Other Websites
    LLY's quarterly checkup: CEO Jan 30 2015
    AstraZeneca, MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/... Jan 29 2015
    No Signs of Weakness at Facebook, But Shares Still Too Pricey Jan 29 2015
    6:46 am AstraZeneca announces four research collaborations aimed at harnessing the power of CRISPR,... Jan 29 2015
    AstraZeneca bets on "genetic scissors" for range of new drugs Jan 29 2015
    AstraZeneca bets on gene editing for broad range of new drugs Jan 29 2015
    Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog Jan 28 2015
    Pfizer Will Do Fine Without AstraZeneca Jan 28 2015
    Grab A 5.4% Yield With Centrica PLC, AstraZeneca plc And Direct Line Insurance Group PLC Jan 28 2015
    Pfizer net down on lower sales, higher research, legal costs Jan 27 2015
    Pfizer net down on lower sales, higher research, legal costs Jan 27 2015
    Pfizer May Go Shopping for Growth Jan 27 2015
    Pfizer Edges Ahead On Q4, Even As Forecast Falls Short Jan 27 2015
    Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog Jan 27 2015
    AstraZeneca plc Could Be Back To Growth By 2016 Jan 27 2015
    Pension charge, lower sales slash Bristol-Myers' Q4 profit Jan 27 2015
    Pension charge, lower sales slash Bristol-Myers' Q4 profit Jan 27 2015
    BUZZ-AstraZeneca: generic Nexium arrives in US, 8 mths late Jan 27 2015
    Is a Generic Nexium Purple Pill for You? Jan 26 2015
    Teva's generic version of AstraZeneca's Nexium gets FDA approval Jan 26 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK